Ovarian hormones modulate endothelin A and B receptor expression

Life Sciences

Volumn 159, Issue , 2016, Pages 148-152

  Gohar, Eman Y ^a   Yusuf, Choudhury ^b   Pollock, David M ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF EVANSVILLE   (United States)

Author keywords

Endothelin; Estrogen; ETA receptors; ETB receptors; Progesterone

Indexed keywords

ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ESTROGEN; PROGESTERONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; KIDNEY CORTEX; KIDNEY PARENCHYMA; NONHUMAN; OVARIECTOMY; OVARY; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; ANIMAL; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ESTROGENS; FEMALE; OVARIECTOMY; OVARY; PROGESTERONE; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B;

EID: 84954305917     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2016.01.010     Document Type: Article

References (40)

1. [1] Black, L.J., Sato, M., Rowley, E.R., Magee, D.E., Bekele, A., Williams, D.C., et al. Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J. Clin. Invest. 93 (1994), 63–69.
2. [2] Boesen, E.I., Sasser, J.M., Saleh, M.A., Potter, W.A., Woods, M., Warner, T.D., et al. Interleukin-1beta, but not interleukin-6, enhances renal and systemic endothelin production in vivo. Am. J. Physiol. Ren. Physiol. 295 (2008), F446–F453.
3. [3] Chen, D.D., Dong, Y.G., Yuan, H., Chen, A.F., Endothelin 1 activation of endothelin a receptor/NADPH oxidase pathway and diminished antioxidants critically contribute to endothelial progenitor cell reduction and dysfunction in salt-sensitive hypertension. Hypertension 59 (2012), 1037–1043.
4. [4] Chester, A.H., Yacoub, M.H., The role of endothelin-1 in pulmonary arterial hypertension. Glob. Cardiol. Sci. Pract. 2014 (2014), 62–78.
5. [5] Clozel, M., Clozel, J.P., Effects of endothelin on regional blood flows in squirrel monkeys. J. Pharmacol. Exp. Ther. 250 (1989), 1125–1131.
6. [6] Elmarakby, A.A., Loomis, E.D., Pollock, J.S., Pollock, D.M., NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. Hypertension 45 (2005), 283–287.
7. B receptors in SSc. Rheumatology 47:Suppl. 5 (2008), v27–v28.
8. [8] Gabler, N.B., French, B., Strom, B.L., Liu, Z., Palevsky, H.I., Taichman, D.B., et al. Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension. Chest 141 (2012), 20–26.
9. [9] Ge, Y., Bagnall, A., Stricklett, P.K., Webb, D., Kotelevtsev, Y., Kohan, D.E., Combined knockout of collecting duct endothelin A and B receptors causes hypertension and sodium retention. Am. J. Physiol. Ren. Physiol. 295 (2008), F1635–F1640.
10. [10] Gohar, E.Y., El-gowilly, S.M., El-Gowelli, H.M., El-Demellawy, M.A., El-Mas, M.M., PI3K/Akt-independent NOS/HO activation accounts for the facilitatory effect of nicotine on acetylcholine renal vasodilations: modulation by ovarian hormones. PLoS One, 9, 2014, e95079.
11. [11] Gouva, L., Tsatsoulis, A., The role of estrogens in cardiovascular disease in the aftermath of clinical trials. Hormones 3 (2004), 171–183.
12. [12] Hirata, Y., Emori, T., Eguchi, S., Kanno, K., Imai, T., Ohta, K., et al. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J. Clin. Invest. 91 (1993), 1367–1373.
13. [13] Ho, H.L., Lee, F.Y., Hsu, S.J., Wang, S.S., Hsin, I.F., Huang, H.C., et al. The ability of 17 beta-estradiol to attenuate intrahepatic vasoconstriction to endothelin-1 in female rats is lost in cirrhosis. Ann. Hepatol. 14 (2015), 404–413.
14. 2 + signaling in the IMCD. Am. J. Physiol. Ren. Physiol. 305 (2013), F1099–F1104.
15. [15] Kim, J.M., Kim, T.H., Lee, H.H., Lee, S.H., Wang, T., Postmenopausal hypertension and sodium sensitivity. J. Menopausal Med. 20 (2014), 1–6.
16. [16] Kitada, K., Yui, N., Mori, T., Ohkita, M., Matsumura, Y., Vasoprotective effects of an endothelin receptor antagonist in ovariectomized female rats. Life Sci. 118 (2014), 379–385.
17. B receptors contribute to sex differences in blood pressure elevation in angiotensin II hypertensive rats on a high-salt diet. Clin. Exp. Pharmacol. Physiol. 40 (2013), 362–370.
18. [18] Kittikulsuth, W., Pollock, J.S., Pollock, D.M., Sex differences in renal medullary endothelin receptor function in angiotensin II hypertensive rats. Hypertension 58 (2011), 212–218.
19. [19] Kittikulsuth, W., Sullivan, J.C., Pollock, D.M., ET-1 actions in the kidney: evidence for sex differences. Br. J. Pharmacol. 168 (2013), 318–326.
20. [20] Kohan, D.E., Inscho, E.W., Wesson, D., Pollock, D.M., Physiology of endothelin and the kidney. Compr. Physiol. 1 (2011), 883–919.
21. [21] Kohan, D.E., Rossi, N.F., Inscho, E.W., Pollock, D.M., Regulation of blood pressure and salt homeostasis by endothelin. Physiol. Rev. 91 (2011), 1–77.
22. [22] Krasowski, M.D., Drees, D., Morris, C.S., Maakestad, J., Blau, J.L., Ekins, S., Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction. BMC Clin. Pathol., 14, 2014, 33.
23. [23] Lamping, K.G., Nuno, D.W., Effects of 17 beta-estradiol on coronary microvascular responses to endothelin-1. Am. J. Physiol. Heart Circ. Physiol. 271 (1996), H1117–H1124.
24. [24] Leung, F.P., Tsang, S.Y., Wong, C.M., Yung, L.M., Chan, Y.C., Leung, H.S., et al. Raloxifene, tamoxifen and vascular tone. Clin. Exp. Pharmacol. Physiol. 34 (2007), 809–813.
25. [25] Mendelsohn, M.E., Karas, R.H., The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340 (1999), 1801–1811.
26. [26] Nakano, D., Pollock, D.M., Contribution of endothelin A receptors in endothelin 1-dependent natriuresis in female rats. Hypertension 53 (2009), 324–330.
27. [27] Nishida, M., Hasegawa, Y., Tanida, I., Nakagawa, E., Inaji, H., Ohkita, M., et al. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats. Eur. J. Pharmacol. 614 (2009), 70–76.
28. [28] Okada, K., Yanai, M., Takeuchi, K., Matsuyama, K., Nitta, K., Hayashi, K., et al. Sex differences in the prevalence, progression, and improvement of chronic kidney disease. Kidney Blood Press. Res. 39 (2014), 279–288.
29. [29] Rockey, D.C., Vasoactive agents in intrahepatic portal hypertension and fibrogenesis: implications for therapy. Gastroenterology 118 (2000), 1261–1265.
30. [30] Saleh, M.A., Boesen, E.I., Pollock, J.S., Savin, V.J., Pollock, D.M., Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat. Hypertension 56 (2010), 942–949.
31. [31] Sandberg, K., Ji, H., Sex differences in primary hypertension. Biol. Sex Differ., 3, 2012, 7.
32. B receptor antagonist, in portal hypertensive rats. Hepatology 28 (1998), 655–659.
33. [33] Stauffer, B.L., Westby, C.M., Greiner, J.J., Van Guilder, G.P., Desouza, C.A., Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298 (2010), R261–R265.
34. [34] Suzuki, H., Kondo, K., Chronic kidney disease in postmenopausal women. Hypertens. Res. 35 (2012), 142–147.
35. [35] Takaoka, M., Yuba, M., Fujii, T., Ohkita, M., Matsumura, Y., Oestrogen protects against ischaemic acute renal failure in rats by suppressing renal endothelin-1 overproduction. Clin. Sci. (Lond.) 103:Suppl. 48 (2002), 434s–437s.
36. [36] Taylor, T.A., Gariepy, C.E., Pollock, D.M., Pollock, J.S., Gender differences in ET and NOS systems in ETB receptor-deficient rats: effect of a high salt diet. Hypertension 41 (2003), 657–662.
37. [37] Teede, H.J., Vincent, A., Hormone therapy — where are we now?. Aust. Fam. Physician 40 (2011), 280–285.
38. [38] Tostes, R.C., Fortes, Z.B., Callera, G.E., Montezano, A.C., Touyz, R.M., Webb, R.C., et al. Endothelin, sex and hypertension. Clin. Sci. (Lond.) 114 (2008), 85–97.
39. [39] Vogel, C., Marcotte, E.M., Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 13 (2012), 227–232.
40. [40] Zhang, Y., Knutsen, G.R., Brown, M.D., Ruest, L.B., Control of endothelin-a receptor expression by progesterone is enhanced by synergy with Gata2. Mol. Endocrinol. 27 (2013), 892–908.